Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

A. Espinel-Ingroff, A. Fothergill, M. Ghannoum, E. Manavathu, L. Ostrosky-Zeichner, M. A. Pfaller, M. G. Rinaldi, W. Schell, T. J. Walsh

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (≥50% inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100% at 24 h (MECs, ≤0.015 μg/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7% at 72 h (MECs, 1 to 8 ng/ml) for S. apiospermum and 96.7 to 97.5% at 48 h (MICs, ≥32 μg/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.

Original languageEnglish (US)
Pages (from-to)2180-2182
Number of pages3
JournalJournal of Clinical Microbiology
Volume45
Issue number7
DOIs
StatePublished - Jul 2007

Fingerprint

anidulafungin
Fusarium
Scedosporium
Quality Control
Fungi
Guidelines
Aspergillus
Paecilomyces
Echinocandins
Multicenter Studies
Reading

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Espinel-Ingroff, A., Fothergill, A., Ghannoum, M., Manavathu, E., Ostrosky-Zeichner, L., Pfaller, M. A., ... Walsh, T. J. (2007). Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. Journal of Clinical Microbiology, 45(7), 2180-2182. https://doi.org/10.1128/JCM.00399-07

Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. / Espinel-Ingroff, A.; Fothergill, A.; Ghannoum, M.; Manavathu, E.; Ostrosky-Zeichner, L.; Pfaller, M. A.; Rinaldi, M. G.; Schell, W.; Walsh, T. J.

In: Journal of Clinical Microbiology, Vol. 45, No. 7, 07.2007, p. 2180-2182.

Research output: Contribution to journalArticle

Espinel-Ingroff, A, Fothergill, A, Ghannoum, M, Manavathu, E, Ostrosky-Zeichner, L, Pfaller, MA, Rinaldi, MG, Schell, W & Walsh, TJ 2007, 'Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds', Journal of Clinical Microbiology, vol. 45, no. 7, pp. 2180-2182. https://doi.org/10.1128/JCM.00399-07
Espinel-Ingroff, A. ; Fothergill, A. ; Ghannoum, M. ; Manavathu, E. ; Ostrosky-Zeichner, L. ; Pfaller, M. A. ; Rinaldi, M. G. ; Schell, W. ; Walsh, T. J. / Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. In: Journal of Clinical Microbiology. 2007 ; Vol. 45, No. 7. pp. 2180-2182.
@article{165b8f4011064a1e89ecc3d340485dbb,
title = "Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds",
abstract = "The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (≥50{\%} inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100{\%} at 24 h (MECs, ≤0.015 μg/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7{\%} at 72 h (MECs, 1 to 8 ng/ml) for S. apiospermum and 96.7 to 97.5{\%} at 48 h (MICs, ≥32 μg/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.",
author = "A. Espinel-Ingroff and A. Fothergill and M. Ghannoum and E. Manavathu and L. Ostrosky-Zeichner and Pfaller, {M. A.} and Rinaldi, {M. G.} and W. Schell and Walsh, {T. J.}",
year = "2007",
month = "7",
doi = "10.1128/JCM.00399-07",
language = "English (US)",
volume = "45",
pages = "2180--2182",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

AU - Espinel-Ingroff, A.

AU - Fothergill, A.

AU - Ghannoum, M.

AU - Manavathu, E.

AU - Ostrosky-Zeichner, L.

AU - Pfaller, M. A.

AU - Rinaldi, M. G.

AU - Schell, W.

AU - Walsh, T. J.

PY - 2007/7

Y1 - 2007/7

N2 - The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (≥50% inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100% at 24 h (MECs, ≤0.015 μg/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7% at 72 h (MECs, 1 to 8 ng/ml) for S. apiospermum and 96.7 to 97.5% at 48 h (MICs, ≥32 μg/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.

AB - The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (≥50% inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100% at 24 h (MECs, ≤0.015 μg/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7% at 72 h (MECs, 1 to 8 ng/ml) for S. apiospermum and 96.7 to 97.5% at 48 h (MICs, ≥32 μg/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.

UR - http://www.scopus.com/inward/record.url?scp=34547614064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547614064&partnerID=8YFLogxK

U2 - 10.1128/JCM.00399-07

DO - 10.1128/JCM.00399-07

M3 - Article

C2 - 17475760

AN - SCOPUS:34547614064

VL - 45

SP - 2180

EP - 2182

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 7

ER -